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Abstract
Background: In acute respiratory distress syndrome (ARDS), gas exchange and respiratory system mechanics
(compliance) are severely impaired. Besides ventilatory parameters, the degree of respiratory abnormality can be
influenced by the circulatory state. This study investigated the influence of acute hypovolemia on the respiratory system.
Methods: We performed a secondary analysis of a previous study including 8 pigs with ARDS-like syndrome induced by
lung lavage and surfactant depletion method (ARDS group) and 10 mechanically ventilated pigs with no intervention
(CTRL group). Animals of both groups were subjected to hemorrhage and retransfusion successively. We reanalyzed the
effect of acute blood volume variations on intrapulmonary shunt (shunt), arterial oxygenation (PaO2:FiO2), global oxygen
delivery (DO2) and respiratory system compliance (Crs).
Results: In the ARDS group, after hemorrhage, shunt decreased (−28 +/− 3.5 % (p < 0.001)), respiratory system
compliance (Crs) increased (+5.1 +/− 1.0 ml/cm H2O (p < 0.001)) moreover, there was a concurrent increase in
PaO2:FiO2 (+113 +/− 19.1 mmHg; p < 0.001) but this did not prevent a reduction in DO2 (−317 +/− 49.8 ml/min;
p < 0.001). Following retransfusion, shunt and Crs return towards pre-hemorrhage values. Similar changes, but of
smaller magnitude were observed in the CTRL group, except that no significant changes in oxygenation occurred.
Conclusions: The present analysis suggests that an acute decrease in blood volume results in a decrease in shunt with
a parallel improvement in arterial oxygenation and an increase in Crs during ARDS-like syndrome. Our results strengthen
the importance to integrate the circulatory condition in the analysis of the state of the respiratory system. However, the
translation of this physiological model in a clinical perspective is not straightforward because our model of acute and
severe hemorrhage is not strictly equivalent to a progressive hypovolemia, as could be obtained in ICU by diuretic.
Furthermore, the present model does not consider the impact of blood loss induced decrease of DO2 on other vital
organs function.
Trial registration: ‘Not applicable’.
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Background
Several studies explored the influence of ventilation
parameters during acute respiratory distress syndrome
(ARDS) [1, 2]. However, the influence of hemodynamic
parameters on respiratory characteristics is frequently
neglected. Indeed, animal studies reported that a de-
crease in cardiac output (CO), induced by a reduction
in blood volume [3–5] or by pharmacological interven-
tion [6, 7], may be associated with a decrease in intra-
pulmonary shunt, in normal lung [3, 5] as well as
during ARDS [3, 4, 6, 7]. In addition, other studies re-
ported an increase in intrapulmonary shunt associated
with an increase in CO [5, 8]. Human studies reported
similar results, where a parallel change in CO and
shunt has been observed in normal subjects during exer-
cise [9] or during CO reduction following the use of
positive end-expiratory pressure (PEEP) in patients with
ARDS [10], even if the effect of PEEP on shunt is not only
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related to his effect on CO [11]. Concerning the respira-
tory system compliance (Crs), previous studies reported
conflicting results as some observed an increase [12, 13], a
decrease [5] or no significant changes [14, 15] in Crs re-
lated to hemorrhage. On the other hand, an increase in
pulmonary blood volume has been shown to result in a
decrease in lung compliance [16].
In a previous study exploring the influence of tidal
volume (VT) and respiratory rate (RR) on pulse pres-
sure variations in pigs with ARDS [17], we observed an
unexpected improvement in oxygenation and an increase
in Crs during acute hemorrhage. In order to complete
previous studies on this issue, we analyzed retrospectively
our data with the hypothesis that a decrease in CO due to
hypovolemia, may decrease intrapulmonary shunt, im-
prove Crs and may result in an improvement in arterial
oxygenation during ARDS.
Methods
The present study was a second analysis from a previous
study [17]. The initial experimentation was performed
on 24 domestic pigs. Domestic pigs were selected for the
experiment because of their strong similarity in term of
physiologic values, hemodynamic and respiratory behavior
with humans. In this first analysis only 16 animals have
been included as 8 pigs were excluded. Indeed, five ani-
mals allowed to improve the model (among them 2 ani-
mals died during the experiment), and three animals were
excluded because of technical problems (dysfunction of
the measurement systems). For the present analysis, 18
animals (mean weight of 31.4 ± 3.1 kg) from the 24 con-
sidered in the first study have been included. Four pigs
were excluded due to lack of data needed for the
present analysis and two other animals died during the
experiment.
Ethics statement
The study was approved by the Ethics Committee for
Animal Research at the University Medical Centre and by
the Cantonal Veterinary Office of Geneva, Switzerland
(No 31.1.1043/3127/1). Animals received respectful care
in accordance with the Guide for the Care and Use of
Laboratory Animals (Institute of Laboratory Animal
Resources, 1996).
Preparation
Animals were premedicated with intramuscular azaperon
6 mg kg−1, midazolam 0.5 mg.kg−1, and atropine 0.5 mg.
Anesthesia was induced by isoflurane and maintained by
fentanyl 20 μg.kg−1.h−1, isoflurane 1.5–2.0 % and pancuro-
nium 0.4 mg.kg−1.h−1. Animals were intubated and mech-
anically ventilated (Servo Ventilator 900, Siemens-Elema,
Sweden). FiO2 was set at 0.4 for the control (CTRL) group
and 1.0 for the ARDS group. Tidal volume (VT) was set at
10 ml.kg−1 without positive end expiratory pressure
(PEEP) and respiratory rate (RR) was 15/min with a
fixed inspiratory to expiratory time ratio (1:2). A Swan-
Ganz catheter (CCOmboV, 7.5 F, Edwards Lifesciences™,
Irvine, CA) was placed in the pulmonary artery. Arterial
pressure was recorded in the aorta trough a carotid arterial
catheter. A right internal jugular vein catheter was placed
for central venous pressure (CVP) measurement, drug in-
fusion and blood retransfusion. Heart rate and rhythm
were recorded with a standard 3-lead electrocardiogram.
Measurements
Respiratory system compliance
Airway pressure was monitored (UltimaTM, Datex/
Instrumentarium, Helsinki, Finland). VT was calculated
by digital integration of a flow signal measured by a
pneumotachograph (Gould Godart, model 17212). Quasi-
static Crs was calculated after an inspiratory pause of 3 s
as VT/(plateau airway pressure – PEEP). Flow tracings
were visually checked to ensure the absence of signs of in-
trinsic PEEP [18].
Blood gas tensions
Arterial blood gas (ABG) tensions, hemoglobin (Hb), oxy-
gen saturation (arterial blood oxygen saturation (SaO2) and
mixed venous blood oxygen saturation (SvO2) were
analyzed by an automated oximeter (ABL-505 Analyzer,
Radiometer, Copenhagen, Denmark).
Intrapulmonary shunt
In the ARDS group, shunt was calculated using the stand-
ard formula: Qs/Qt = (CcO2 ‐CaO2)/(CcO2 ‐CvO2) with
the FiO2 set at 1.0.
In the present equation, Qs represents the shunt flow;
Qt represents the systemic blood flow, the CcO2 repre-
sents the pulmonary capillary oxygen content; CaO2, the
arterial oxygen content and CvO2, the mixed venous
oxygen content. Oxygen content in arterial venous and
capillary blood where calculated as: (1.34 × oxygen blood -
saturation × hemoglobin [Hb]) – (PO2 × 0.003). In the
CTRL group, as FiO2 was set at 0.4 therefore, the calcula-
tion of shunt represent venous admixture.
Global oxygen delivery
DO2 was calculated as the product of CaO2 and CO,
where CaO2 was calculated as 1.34 × Hb × SaO2 +
(0.003 × PaO2).
Hemodynamic and respiratory measurements were
digitized using an analog/digital interface converter
(Biopac, Santa Barbara, CA, USA) and stored for off-
line analysis.
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Experimental protocol
Animals were separated into two groups. The CTRL
group (n = 10) received anesthesia and controlled mech-
anical ventilation but no intervention. The ARDS group
(n = 8) was submitted to a procedure of surfactant deple-
tion to induce an ARDS-like syndrome [19]. This pro-
cedure consisted of lung lavage with NaCl 0.9 %
(1000 ml) at 37 °C repeated until criteria for ARDS
were fulfilled (PaO2/FiO2 < 200 mmHg). This required a
mean ± SD of 3.1 ± 0.3 lung lavage at 12.6 ± 3.5 min
intervals.
During hemorrhage total blood volume was reduced by
40 % of (estimated at 70 ml.kg−1 body weight) over 5–
10 min. Removed blood was stored at body temperature
in bags containing citrate-phosphate-dextrose (Baxter AG,
Volketswil, Switzerland) and was totally retransfused
during the retransfusion period. The mean time be-
tween the start of bleeding until completed retransfu-
sion was 49 ± 11 min.
Measurement were assessed at pre-hemorrhage, he-
morrhage, and retransfusion period in the CTRL group
and at baseline (pre-ARDS), pre-hemorrhage (post-ARDS),
hemorrhage and retransfusion in the ARDS group. As the
original study was designed to investigate the influence of
VT and RR on pulse pressure variations, three variants of
ventilation were used successively during each period:
V1 = VT 10 ml.kg
−1 and RR 15 min−1; V2 = VT 6 ml.kg
−1
and RR 25 min−1; and V3 =VT 6 ml.kg
−1 and RR 15 min−1
(5–7 min each).
Statistical analysis
Data are presented as mean ± SD or as mean changes
between periods ± SE. Baseline measures (pre-ARDS) in
the ARDS group were not included in the statistical ana-
lyses. To determine the influence of hemorrhage on
measured variables, we used a mixed effects analysis of
variance (ANOVA) with fixed effect for the 3 periods of
the experiment and random effect for pig (8 or 10). The
same model was used to analyze the changes of the
major determinants of DO2 (CaO2, Hb and SaO2,) in the
ARDS group only. This statistical model estimates all
comparisons between time periods simultaneously, redu-
cing the risk of type I error. Furthermore, it takes into
account repeated measurements of each pig across pe-
riods and across variants of ventilation. We determined
the significance of the effect of hemorrhage and retrans-
fusion on these parameters. As the goal of the analysis
was to determine the effect of acute hemorrhage on shunt
and Crs and because in the CTRL group venous admixture
rather than true shunt was estimated, we did not compare
the two groups of animals. Results are presented as the
mean difference between two periods (hemorrhage vs pre-
hemorrhage; retransfusion vs hemorrhage; retransfusion vs
prehemorrhage) with respective p values. Because SvO2
may influence PaO2:FiO2 through venous admixture [20]
we also analyzed PaO2:FiO2 adjusted for SvO2. After visual
inspection of the data in order to determine the effect of
successive ventilation mode on shunt in the ARDS group,
we performed a mixed effects analysis of variance of the
shunt across variant of ventilation. Comparison of blood
loss between the CTRL group and the ARDS group were
performed using unpaired t-test. All analyses were per-
formed with R software (Version 2.15.1). A value of p less
than 0.05 was considered significant and all statistical tests
were two-tailed.
Results
Results are presented in Figs. 1 and 2, Tables 1 and 2.
Mean difference and results of statistical analysis between
periods are shown in Table 3.
Hemodynamics
The blood volume removed from the animals was 936 ±
100 ml (30 ml/kg) and 909 ± 94 ml (29 ml/kg) in the
CTRL and ARDS group respectively (p > 0.05). CO
(Figs. 1 and 2), mean arterial pressure and CVP de-
creased during the hemorrhage and recovered to base-
line values during retransfusion (Table 3). The only
exception was CVP in the ARDS group, which was
slightly but significantly higher after retransfusion than
pre-hemorrhage.
Gas exchange, oxygen delivery and compliance
In the CTRL group (Fig. 1), venous admixture decreased
during hemorrhage and recovered to pre-hemorrhage
values during retransfusion (Table 1). In the ARDS
group (Fig. 2), shunt decreased during hemorrhage and
recovered during re-transfusion, but did not fully return
to pre-hemorrhage values (Table 2). In the CTRL group
(Fig. 1), even if shunt changed, PaO2:FiO2, was similar
across pre-hemorrhage, hemorrhage and retransfusion
phases (Table 1). On the other hand, in the ARDS group
(Fig. 2), PaO2:FiO2 varies inversely from shunt: increased
during hemorrhage and did not recover completely during
retransfusion (Table 2). The adjustment of PaO2:FiO2 for
SvO2 did not change these results.
For both groups, DO2 varied in accordance with CO.
That is, DO2 decreased during hemorrhage and then re-
covered during retransfusion (CTRL group: Fig. 1; Table 1;
ARDS group: Fig. 2; Table 2). The main determinants of
DO2 were examined in the ARDS group. CaO2 did not
change across the phases (Table 2), Hb remained stable
across the phases and SaO2 increased during hemorrhage
but did not recover during re-transfusion (Table 2).
For both groups, Crs increased during hemorrhage
and recovered to pre-hemorrhage values during retrans-
fusion (CTRL group: Fig. 1; Table 1; ARDS group: Fig. 2;
Table 2).
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Fig. 1 (See legend on next page.)
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Impact of changes in ventilation settings on shunt in the
ARDS group
At baseline (pre-ARDS), shunt did not change with ven-
tilation setting (V1 to V2 change = 5.12 % (p = 0.19), V2
to V3 change = −1.83 (p = 0.61)). After ARDS induction
but before hemorrhage (pre-hemorrhage period), shunt
was only affected by the change from V1 to V2
(change = 15.16, p = 0.01) but not from V2 to V3
(change = 3.10, p = 0.57). After hemorrhage and
retransfusion, there were no statistically significant dif-
ferences in shunt values when ventilation was switched
from V1 to V2 or from V2 to V3.
Discussion
In the present animal study, the authors investigated the
effect of a decrease in CO through acute severe hypo-
volemia (with neither a pharmacologic intervention nor
a mechanical procedure) on intra-pulmonary shunt in
healthy and ARDS animals. Our analysis suggests that
severe hypovolemia induced by acute hemorrhage is as-
sociated with a decrease in shunt and an increase in
Crs in a pig model of ARDS. These changes were asso-
ciated with improvements in PaO2:FiO2 only at high
values of shunt (ARDS-like syndrome). The improve-
ment in PaO2:FiO2 did not compensate for the decrease
in CO and, as a consequence, DO2 decreased. To our
knowledge, this is the first study showing the effects of
acute hemorrhage on Crs in ARDS pig model.
In the present study, we observed that shunt and blood
oxygenation were influenced by acute hemorrhage (shunt
decrease) and retransfusion (shunt increase). Moreover, as
during ARDS oxygenation is closely related to shunt
[21, 22], PaO2:FiO2 varied similarly to shunt. This rela-
tion between global perfusion and shunt has already
been reported during a decrease and an increase in per-
fusion [4, 6–10]. However, the present study extends
these results to demonstrate that this relation is associ-
ated with concomitant changes in respiratory system
compliance and that the effects on PaO2:FiO2 are not
observed for relatively moderate values of shunt.
The decrease in shunt during hemorrhage could be ex-
plained by several physiological mechanisms. Firstly, it
may be related to a preferential decrease in the perfusion
of low- and/or non-ventilated regions. Indeed, to have a
significant impact on oxygenation, the decrease in lung
perfusion must be larger in the shunted part of the lung
than in other normal lung regions. In ARDS, shunt
essentially resides in the injured areas of the lung, in
which perfusion is already limited by microvascular ob-
struction [23], adaptative hypoxic vasoconstriction [24],
and gravitational compression of vessels [25, 26]. Sec-
ondly, in regions with lung injury, the impaired oxygen-
ation and apparent “shunt” could also be explained by a
decrease in pulmonary transit time in which the blood
cannot be fully oxygenated because of increased red cell
velocity [27, 28]. Thus, when the animals are hemor-
rhaged and pulmonary flow reduced, the reduced flow
velocity may be coupled to a more efficient blood oxygen-
ation. Finally, changes in Crs may also have influenced
PaO2:FiO2 as suggested by the significant correlation be-
tween the changes in Crs and the changes in PaO2:FiO2
observed in our analysis and reported in Fig. 3. As the
increase in Crs decreased alveolar pressures it may re-
sult in an improvement in the perfusion of West zone
II [29] that may have reduced shunt.
The other means by which shunt could be decreased
is to recruit poorly or non-ventilated lung. However, in
our analysis, the decrease in shunt and the concurrent
improvement in PaO2:FiO2 remained significant what-
ever the VT value. This may be related to the fact that,
during ARDS, pure shunt is predominant [6, 10] and
small changes in VT value will not have a significant im-
pact. Indeed, in the ARDS group, shunt significantly in-
creased when VT was decreased from 10 ml.kg
−1 (V1) to
6 ml.kg−1 (V2) during normovolemia but not during
hemorrhage, confirming that the circulatory state was
the main determinant of the shunt during Hypovolemia
(Fig. 1; Table 2). As well, although the calculated shunt
in the CTRL group was overestimated (since the calcula-
tion of shunt at FiO2 lower than 100 % represents ven-
ous admixture and not a true shunt [30]), the impact of
bleeding on CTRL group PaO2:FiO2 was low, demon-
strating that the circulatory state remains a determinant
of the shunt only when lungs are affected by atelectasis.
However, even if gas exchange (PaO2:FiO2) and SaO2
improved during hemorrhage, it does not result in better
tissue oxygenation. Indeed, the improvement in SaO2
was not large enough to influence CaO2, due in part to a
slight decrease in hemoglobin. As a consequence, the de-
crease in CO reduced DO2. However, as the initial study
was not designed to measure tissue oxygenation abnor-
malities, the impact of this decrease of DO2 on other vital
organs function have not be investigated in the present
analysis. Nevertheless, our observation is relevant to
(See figure on previous page.)
Fig. 1 This figure shows the evolution of measured parameters during the experiment in the control group. All values are presented for each
mode of ventilation (V1, V2, V3) in the successive phase of the experiment (Baseline, Hemorrhage, Re-transfusion). Crs, respiratory system compliance;
CO, cardiac output; DO2, oxygen delivery; MAP, mean arterial pressure V1, tidal volume: 10 ml.kg−1 and respiratory rate: 15 min−1; V2 = tidal volume:
6 ml.kg−1 and respiratory rate: 25 min−1; V3, tidal volume 6 ml.kg−1 and respiratory rate: 15 min−1
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Fig. 2 This figure shows the evolution of measured parameters during the experiment in the ARDS group. All values are presented for each
mode of ventilation (V1, V2, V3) in the successive phase of the experiment (Baseline, ARDS, Hemorrhage, Re-transfusion). Crs, respiratory system
compliance; CO, cardiac output; DO2, oxygen delivery; MAP, mean arterial pressure; shunt, intrapulmonary shunt; V1, tidal volume: 10 ml.kg−1 and
respiratory rate: 15 min−1; V2 = tidal volume: 6 ml.kg−1 and respiratory rate: 25 min−1; V3, tidal volume 6 ml.kg−1 and respiratory rate: 15 min−1
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Table 1 Hemodynamic, respiratory and oxygenation parameters during each mode of ventilation at each time point in the control group
Pre-hemorrhage Mean ± SD Hemorrhage Mean ± SD Retransfusion Mean ± SD
Ventilation mode:
Tidal volume:ml.k g-1 VT:10 VT:6 VT:6 Average across
variants of ventilation
VT:10 VT:6 VT:6 Average across
variants of ventilation




RR: 15 RR: 25 RR: 15 RR: 15 RR: 25 RR: 15 RR: 15 RR: 25 RR: 15
Cardiac output (l.min-1) 5.4 ± 1.4 5.7 ± 1.5 6.0 ± 1.9 5.7 ± 1.6 3.6 ± 0.8 3.1 ± 1.1 2.6 ± 1.6 3.1 ± 1 5.3 ± 1.7 5.1 ± 2.5 5.1 ± 2.6 5.1 ± 2.2
Heart Rate (bpm) 101 ± 32 100 ± 26 103 ± 24 101 ± 27 130 ± 25 154 ± 50 163 ± 55 150 ± 46 111 ± 30 114 ± 25 120 ± 27 115 ± 26
Mean arterial pressure
(mmHg)
95 ± 13 98 ± 15 97 ± 14 96.8 ± 13.7 51 ± 15 59 ± 16 64 ± 13 58.1 ± 15.4 96 ± 10 95 ± 9 95 ± 10 95.2 ± 9.3
Central venous pressure
(mmHg)
8 ± 1 7 ± 1 7 ± 2 8 ± 1 5 ± 2 5 ± 3 6 ± 3 5 ± 3 9 ± 2 7 ± 3 8 ± 1 8 ± 2
Veinous admixture (%) 13 ± 4 18 ± 8 18 ± 9 16 ± 7 8 ± 4 10 ± 4 17 ± 14 11 ± 9 12 ± 4 14 ± 5 25 ± 12 16 ± 9
PaO2:FiO2 (mmHg) 426 ± 72 393 ± 92 345 ± 91 388 ± 89 403 ± 72 404 ± 87 340 ± 90 385 ± 84 441 ± 59 408 ± 54 316 ± 82 395 ± 79
SVO2 (%) 78 ± 8 78 ± 5 76 ± 8 77 ± 7.0 60 ± 12 65 ± 10 64 ± 15 63 ± 12 82 ± 5 78 ± 8 77 ± 6 79 ± 7
Global oxygen delivery
(ml.min-1.m-2)



















Table 2 Hemodynamic, respiratory and oxygenation parameters during each mode of ventilation at each time point in the ARDS group (n = 8)
Ventilation mode Pre-hemorrhage mean ± SD Hemorrhage mean ± SD Retransfusion mean ± SD
Ventilation mode:
VT:ml.kg-1 VT:10 VT:6 VT:6 Average across
variants of ventilation
VT:10 VT:6 VT:6 Average across
variants of ventilation
VT:10 VT:6 VT:6 Average across
variants of ventilation
RR: breaths/min RR: 15 RR: 25 RR: 15 RR: 15 RR: 25 RR: 15 RR: 15 RR: 25 RR: 15
Cardiac output
(l.min-1)
6.7 ± 1.3 6.8 ± 1.5 7.6 ± 1.4 7.0 ± 1.4 3.6 ± 0.9 3.4 ± 0.8 4.5 ± 1.0 3.8 ± 1.0 6.9 ± 3.0 7.4 ± 2.6 8.2 ± 2.1 7.5 ± 2.5
Heart rate (bpm) 145 ± 18 157 ± 30 171 ± 36 158 ± 30 210 ± 24 215 ± 17 209 ± 29 212 ± 22 172 ± 32 170 ± 27 181 ± 24 174 ± 27
Mean arterial pressure
(mmHg)
77 ± 19 87 ± 14 88 ± 13 84.0 ± 16.0 51 ± 13 67 ± 16 67 ± 12 62 ± 15 79 ± 10 85 ± 10 84 ± 12 83 ± 11
Central venous
pressure (mmHg)
8 ± 2 7 ± 2 7 ± 2 8 ± 2 6 ± 2 5 ± 1 5 ± 2 5 ± 1 9 ± 1 8 ± 1 8 ± 1 9 ± 1
Shunt (%) 26 ± 15 41 ± 12 45 ± 15 37 ± 16 6 ± 7 8 ± 6 11 ± 9 9 ± 7 16 ± 17 20 ± 16 27 ± 19 20 ± 18
PaO2:FiO2 (mmHg) 105 ± 38 76 ± 20 75 ± 19 85 ± 30 218 ± 105 201 ± 95 177 ± 80 199 ± 91 207 ± 125 157 ± 77 133 ± 59 166 ± 93
SVO2 (%) 69 ± 11 70 ± 9 69 ± 11 69 ± 10 59 ± 14 67 ± 15 67 ± 17 64 ± 15 79 ± 7 79 ± 8 81 ± 8 80 ± 7
Global oxygen delivery
(ml.min-1.m-2)
731 ± 146 701 ± 219 798 ± 265 744 ± 210 408 ± 113 369 ± 114 501 ± 160 427 ± 137 740 ± 392 846 ± 404 961 ± 323 849 ± 370
Arterial content in
oxygen (ml.dl-1)
11.0 ± 0.9 10.2 ± 1.5 10.4 ± 1.7 10.5 ± 1.4 10.9 ± 1.3 10.9 ± 1.5 11.0 ± 1.5 11.0 ± 1.4 11.5 ± 1.0 11.2 ± 1.6 11.6 ± 1.1 11.4 ± 1.2
Hemoglobin (g.dl-1) 8.4 ± 0.4 8.4 ± 0.6 8.6 ± 0.8 8.5 ± 0.6 7.6 ± 0.6 7.7 ± 0.8 7.9 ± 0.7 7.8 ± 0.7 8.1 ± 1.0 8.1 ± 1.3 8.6 ± 0.8 8.3 ± 1.0



















Table 3 Impact of hemorrhage and retransfusion on hemodynamic, respiratory and oxygenation parameters
Phase Hemorrhage vs.
pre-hemorrhage
Retransfusion vs. hemorrhage Retransfusion vs.
pre-hemorrhage
Parameter Group Mean difference ± SE p Mean difference ± SE p Mean difference ± SE p
Hemodynamic
Cardiac output, l.min−1 CTRL −2.6 ± 0.3 <0.001 2.4 ± 0.3 <0.001 −0.2 ± 0.3 0.48
ARDS −3.2 ± 0.4 <0.001 3.7 ± 0.4 <0.001 0.5 ± 0.4 0.21
Mean arterial pressure, mmHg CTRL −36.7 ± 3.1 <0.001 36.6 ± 3.2 <0.001 −0.1 ± 3.1 0.98
ARDS −22 .4 ± 4.0 <0.001 21.4 ± 4.1 <0.001 −1.0 ± 4.1 0.80
Central venous pressure, mmHg CTRL −2.3 ± 0.3 <0.001 2.9 ± 0.4 <0.001 0.6 ± 0.3 0.09
ARDS −2.2 ± 0.3 <0.001 3.2 ± 0.3 <0.001 1 ± 0.3 0.003
Respiratory system and oxygenation
Venous admixture, % CTRL −6.1 ± 1.9 0.002 4.9 ± 1.9 0.01 −1.2 ± 1.8 0.50
Shunt, % ARDS −28.5 ± 3.5 <0.001 12.3 ± 3.5 <0.001 −16.1 ± 3.5 <0.001
PaO2:FiO2, mmHg CTRL 1.7 ± 17.0 0.92 13.2 ± 17.2 0.45 14.5 ± 16.5 0.37
ARDS 113.4 ± 19.1 <0.001 −33.3 ± 19.1 0.09 80.2 ± 19.1 <0.001
PaO2:FiO2 adjusted for mixed
venous blood saturation, mmHg
CTRL 42.6 ± 23.8 0.08 −33.1 ± 25.3 0.20 9.4 ± 16.2 0.56
ARDS 125.7 ± 19.2 <0.001 −71.3 ± 22.5 0.002 54.4 ± 20.6 0.01
Global oxygen delivery, ml.min-1.m−2 CTRL −290.8 ± 37.0 <0.001 229.6 ± 38.4 <0.001 −61.1 ± 35.9 0.09
ARDS −316.9 ± 49.8 <0.001 422.1 ± 49.8 <0.001 105.3 ± 49.8 0.04
Arterial content in oxygen, ml.dl−1 ARDS 0.4 ± 0.6 0.51 0.5 ± 0.6 0.48 0.9 ± 0.6 0.18
Hemoglobin, g.dl−1 ARDS −0.7 ± 0.4 0.08 0.5 ± 0.4 0.18 0.2 ± 0.4 0.65
Arterial blood saturation, % ARDS 9.0 ± 2.6 0.004 −1.0 ± 2.6 0.76 8.0 ± 2.6 0.008
Respiratory system compliance, ml.cm H2O
−1 CTRL 2.5 ± 0.9 0.006 −2.6 ± 0.9 0.01 −0.1 ± 0.9 0.94
ARDS 5.1 ± 1.0 <0.001 −3.3 ± 1.0 0.001 1.8 ± 1.0 0.07
Fig. 3 This figure report the relation between the changes (%) in PaO2:FiO2 and the changes (%) in Crs after hemorrhage and retransfusion. The
correlation coefficient (r2) describes how two variables vary together
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clinical settings, as it indicates that an improvement in
PaO2:FiO2 and SaO2 can falsely mask a worsening in
systemic oxygen delivery.
A key result in this study is the observed changes in
Crs following blood volume shift (hemorrhage and
retransfusion) (Table 3). An influence of blood volume
on Crs has already been reported during blood volume
decrease [12, 13] or increase [16], but previous studies
reported conflicting results as they reported either a de-
crease [5, 31] or a stable [14, 15] Crs following hemorrhage.
None of these studies investigated this effect during ARDS.
One explanation for the inconsistency in previous results
could be related to the variable and interrelated impact of
blood volume on the total lung volume (including air, blood
and tissue) and the participation of the microvascular net-
work to the stiffness of the lung tissue. Indeed, considering
the relation between pulmonary vascular pressure/filling
and lung mechanical characteristics, various studies sug-
gests that the pressurized pulmonary capillary network act
as a tether for the lung tissue which may influence respira-
tory mechanics stability [32, 33].
This study acknowledges some limitations. First of all,
the present report and analysis are based on previous ex-
perimentations [17] in which the main goal was far away
from considering the impact of CO on intrapulmonary
shunt. However, this secondary analysis of previously
collected data is an ethical way to study further concepts
without performing new experimentations and minimizing,
by the way, the use of animals. Moreover, even if the design
of the initial study was not specifically adapted to the aim
of the present analysis, our results are in accordance with
physiological laws and support previous works on this
subject. Second, animals were ventilated without PEEP.
Adding PEEP could have limited the development of
atelectatic regions resulting in a model without significant
shunt and decreased Crs, which could not allow investigat-
ing the specific effect of hemorrhage on these parameters.
Consequently, we could not totally extrapolate the effects
of hemorrhage on shunt and Crs in situations of ARDS
ventilated with PEEP. However in patients with ARDS,
even if high PEEP is used, the remaining hypoxemia is pre-
dominantly related to persistent shunt that could be influ-
enced by the changes in CO. Third, our model of ARDS
induced by a surfactant depletion method is a classical
model of ARDS-like syndrome in animals resulting in re-
producible and stable changes in physiological parameters
similar to human ARDS [34]. However, this model is
mainly characterized by atelectasis and less inflammatory
lesions. Third, due to the design of the initial study [17],
animals were ventilated with three successive ventilation
modes. These changes in ventilatory settings could have in-
fluenced measured parameters. However, we used a mixed
model ANOVA taking into account the effect of ventilation
mode. Moreover, when we analyzed the impact of changes
in ventilatory settings on shunt in the ARDS group, the
mode of ventilation affected shunt only in the pre-
hemorrhage period and between V1:VT: 10 ml.kg
−1, RR:
15 min−1 and V2: VT: 6 ml.kg-1, RR: 25 min
−1 but not in
other period nor other change in ventilation mode. There-
fore, the ventilation mode used in this study does not seem
to influence significantly the measured parameters. Fourth,
the translation of this physiological model in a clinical
perspective is not straightforward: our model of acute and
severe hemorrhage is not strictly equivalent to a progres-
sive hypovolemia, as could be obtained by diuretic for
example. However, our results consolidate the hypothesis
that decrease in blood volume may influence respiratory
system characteristics, especially when these characteristics
are already altered. Moreover it emphasizes that the influ-
ence of a decrease in blood volume on SaO2 or PaO2:FiO2
may be at the expense of global oxygen delivery. Our
model may be more closely encountered for example
during the institution or the weaning of extracorporeal
membrane oxygenation (ECMO) where large and acute
changes in circulating blood volume may influence respira-
tory system characteristics. Finally, the compensatory re-
lease of catecholamine associated with the acute severe
hemorrhage model may have influenced our observation.
Indeed, catecholamine increase pulmonary vascular re-
sistance [35] which may have amplified the decrease in
pulmonary shunt observed during hemorrhage.
Conclusion
Our observations show that there is an impact of blood
volume on respiratory system characteristics and oxy-
genation parameters during ARDS. Indeed, we observed
that an acute hemorrhage results in a decrease in shunt
with a parallel improvement in arterial oxygenation.
Moreover, after hemorrhage, Crs improves. Our observa-
tions illustrate the link between physiologic mechanisms
and clinical observations and may explain why in clinical
practice a rapid modest improvement in lung compliance
and/or a large improvement in oxygenation parameters in
patients with ARDS may not necessarily reflect an im-
provement in patient condition but rather may be related
to an acute decrease in transpulmonary blood flow. Our
analysis thus strengthens the importance to integrate the
circulatory condition in the analysis of the state of the re-
spiratory system. However, the caveats of the study (use of
a model not replicable in clinical activity; lack of data on
the impact of oxygen delivery on clinical outcome) do not
allow having a reliable take-home message for the clinical
management of ARDS.
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